Making medicines safer: analysis of patient reports to the UK’s Yellow Card Scheme

References

• Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624–1632.
   PubMedGoogle Scholar
• De Langen J, Van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31(6):515–524.
   PubMed Web of Science ®Google Scholar
• Avery AJ, Anderson C, Bond CM, et al. Evaluation of patient reporting of adverse drug reactions to the UK “Yellow card scheme”: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1–234.
   PubMed Web of Science ®Google Scholar
• Hazell L, Cornelius V, Hannaford P, et al. How do patients contribute to signal detection? : a retrospective analysis of spontaneous reporting of adverse drug reactions in the UK’s Yellow Card Scheme. Drug Saf. 2013;36(3):199–206.
   PubMed Web of Science ®Google Scholar
• Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2017;83(2):227–246.
   PubMed Web of Science ®Google Scholar
• Rolfes L, van Hunsel F, van der Linden L, et al. The quality of clinical information in adverse drug reaction reports by patients and healthcare professionals: a retrospective comparative analysis. Drug Saf. 2017;40(7):607–614.
   PubMed Web of Science ®Google Scholar
• Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med. 2004;16(1):5–19.
   Google Scholar
• Herxheimer A. Pharmacovigilance on the turn? Adverse reactions methods in 2012. Brit J Gen Pract. 2012;62:400–401.
   PubMed Web of Science ®Google Scholar
• Van Hunsel F, Härmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients: an 11 country survey. Drug Saf. 2012;35(1):45–60.
   PubMed Web of Science ®Google Scholar
• Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf. 2014;37(6):409–419.
   PubMed Web of Science ®Google Scholar
• Banovac M, Candore G, Slattery J, et al. Patient reporting in the EU: analysis of EudraVigilance data. Drug Saf. 2017;40(7):629–645.
   PubMed Web of Science ®Google Scholar
• Radecka A, Loughlin L, Foy M, et al. Enhancing pharmacovigilance capabilities in the EU regulatory network: the SCOPE joint action. Drug Saf. 2018;41(12):1285–1302.
   PubMed Web of Science ®Google Scholar
• Jadeja M. Social media campaign raises awareness of ADR reporting. Uppsala Reports, Issue 78, April 2018, pg 30–31. [cited 2019 Mar 6]. Available from: https://www.who-umc.org/media/164251/uppsalareports78web.pdf
   Google Scholar
• Jadeja M. ADR reporting awareness on social media. Uppsala Reports, Issue 75, April 2017, pg 20–23. [cited 2019 Mar 6]. Available from: https://www.who-umc.org/media/3108/uppsalareports75web_new.pdf
   Google Scholar
• Medicines and Healthcare Regulatory Agency. 2018 [cited 2019 Mar 6]. Animations, infographics and videos. Available from: https://yellowcard.mhra.gov.uk/downloadable-information/animations-and-vidoes/animations-and-infographics-on-the-yellow-card-scheme/
   Google Scholar
• Medicines and Healthcare Regulatory Agency. 2018 [cited 2019 Mar 6]. Help make medicines safer: report suspected side effects in children and during pregnancy. Available from: https://www.gov.uk/government/news/help-make-medicines-safer-report-suspected-side-effects-in-children-and-during-pregnancy
   Google Scholar
• McLernon DJ, Bond CM, Hannaford PC, on behalf of the Yellow Card Study Collaboration, et al. Adverse drug reaction reporting in the UK: a retrospective observational comparison of Yellow Card reports submitted by patients and healthcare professionals. Drug Saf. 2010;33:775–788.
   PubMed Web of Science ®Google Scholar
• Human Medicines Regulations 2012 Advisory Bodies Annual Report 2015.
   Google Scholar
• Human Medicines Regulations 2012 Advisory Bodies Annual Report 2017.
   Google Scholar
• Clarke MA, Moore JL, Steege LM, et al. Health information needs, sources, and barriers of primary care patients to achieve patient-centered care: a literature review. Health Informatics J. 2016;22(4):992–1016.
   PubMed Web of Science ®Google Scholar
• Casiday RE, Cox AR. Restoring confidence in vaccines by explaining vaccine safety monitoring: is a targeted approach needed? Drug Saf. 2006;29(12):1105–1109.
   PubMed Web of Science ®Google Scholar
• NHS Digital. 2017. Health Survey for England 2016: prescribed medicines.
   Google Scholar
• Lehnert T, Heider D, Leicht H, et al. Health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev. 2011;68(4):387–420.
   PubMed Web of Science ®Google Scholar
• Krska J, Katusiime B, Corlett SA. Patient experiences of the burden of long-term medicines use and factors affecting burden: a cross-sectional survey. Health Soc Care Community. 2018;26:946–959.
   PubMed Web of Science ®Google Scholar
• Bowling A, Rowe G, Lambert N, et al. The measurement of patients’ expectations for health care: a review and psychometric testing of a measure of patient’s expectations. Health Technol Assess. 2012;16:30.
   Web of Science ®Google Scholar
• Loikas D, Wettermark B, Euler M, et al. Differences in drug utilisation between men and women: a cross‐sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3(5):e002378.
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen J, Li D, et al. Systematic analysis of adverse event reports for sex differences in adverse drug events. Sci Rep. 2016;6(1):24955.
   PubMed Web of Science ®Google Scholar
• de Vries ST, Denig P, Ekhart C, et al. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: an explorative observational study. Br J Clin Pharmacol. 2019 Apr 2. DOI:10.1111/bcp.13923.
   Web of Science ®Google Scholar
• NHS Digital. Prescriptions Dispensed in the Community - England, 2007 to 2017.
   Google Scholar
• Fine M. Quantifying the impact of NSAID-associated adverse events. Am J Manag Care. 2013;19(14 Suppl):s267–72.
   PubMed Web of Science ®Google Scholar
• Dolk FCK, Pouwels KB, Smith DRM, et al. Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? J Antimicrob Chemother. 2018;73(2):ii2–ii10.
   PubMed Web of Science ®Google Scholar